Search research articles
Contact Us
Filters
Showing results (451-460 of 662) with videos related to
Page
of 67
Sort By:
Blood
|
August 8, 2008
Leukemic challenge unmasks a requirement for PI3Kdelta in NK cell-mediated tumor surveillance
Eva Zebedin, Olivia Simma, Christian Schuster, et al.
The Journal of Allergy and Clinical Immunology
|
April 17, 2022
Clinical impact and proposed application of molecular markers, genetic variants, and cytogenetic analysis in mast cell neoplasms: Status 2022
Michel Arock, Gregor Hoermann, Karl Sotlar, et al.
The Journal of Allergy and Clinical Immunology
|
October 2, 2007
Mast cell-derived proteases control allergic inflammation through cleavage of IgE
Ingrid Rauter, Maria-Theresa Krauth, Kerstin Westritschnig, et al.
Nature Chemical Biology
|
October 2, 2012
Systems-pharmacology dissection of a drug synergy in imatinib-resistant CML
Georg E Winter, Uwe Rix, Scott M Carlson, et al.
Blood
|
June 27, 2008
Oncogenic Kit controls neoplastic mast cell growth through a Stat5/PI3-kinase signaling cascade
Noria Harir, Cédric Boudot, Katrin Friedbichler, et al.
Journal of Affective Disorders
|
August 5, 2023
Affective temperament, fatigue, and pain in cancer patients
Matthias Knefel, Elisabeth L Zeilinger, Andreas Erfurth, et al.
Haematologica
|
October 4, 2016
Advanced systemic mastocytosis: from molecular and genetic progress to clinical practice
Celalettin Ustun, Michel Arock, Hanneke C Kluin-Nelemans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 27, 2011
Coalesced multicentric analysis of 2,351 patients with myelodysplastic syndromes indicates an underestimation of poor-risk cytogenetics of myelodysplastic syndromes in the international prognostic scoring system
Julie Schanz, Christian Steidl, Christa Fonatsch, et al.
Haematologica
|
December 2, 2016
The myeloma stem cell concept, revisited: from phenomenology to operational terms
Hans Erik Johnsen, Martin Bøgsted, Alexander Schmitz, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
February 25, 2021
COVID-19 infection in patients with mast cell disorders including mastocytosis does not impact mast cell activation symptoms
Matthew P Giannetti, Emily Weller, Iván Alvarez-Twose, et al.
Page
of 67
Search research articles
Search
Showing results (451-460 of 662) with videos related to
Sort By:
Page
of 67
Blood
|
August 8, 2008
Leukemic challenge unmasks a requirement for PI3Kdelta in NK cell-mediated tumor surveillance
Eva Zebedin, Olivia Simma, Christian Schuster, et al.
The Journal of Allergy and Clinical Immunology
|
April 17, 2022
Clinical impact and proposed application of molecular markers, genetic variants, and cytogenetic analysis in mast cell neoplasms: Status 2022
Michel Arock, Gregor Hoermann, Karl Sotlar, et al.
The Journal of Allergy and Clinical Immunology
|
October 2, 2007
Mast cell-derived proteases control allergic inflammation through cleavage of IgE
Ingrid Rauter, Maria-Theresa Krauth, Kerstin Westritschnig, et al.
Nature Chemical Biology
|
October 2, 2012
Systems-pharmacology dissection of a drug synergy in imatinib-resistant CML
Georg E Winter, Uwe Rix, Scott M Carlson, et al.
Blood
|
June 27, 2008
Oncogenic Kit controls neoplastic mast cell growth through a Stat5/PI3-kinase signaling cascade
Noria Harir, Cédric Boudot, Katrin Friedbichler, et al.
Journal of Affective Disorders
|
August 5, 2023
Affective temperament, fatigue, and pain in cancer patients
Matthias Knefel, Elisabeth L Zeilinger, Andreas Erfurth, et al.
Haematologica
|
October 4, 2016
Advanced systemic mastocytosis: from molecular and genetic progress to clinical practice
Celalettin Ustun, Michel Arock, Hanneke C Kluin-Nelemans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 27, 2011
Coalesced multicentric analysis of 2,351 patients with myelodysplastic syndromes indicates an underestimation of poor-risk cytogenetics of myelodysplastic syndromes in the international prognostic scoring system
Julie Schanz, Christian Steidl, Christa Fonatsch, et al.
Haematologica
|
December 2, 2016
The myeloma stem cell concept, revisited: from phenomenology to operational terms
Hans Erik Johnsen, Martin Bøgsted, Alexander Schmitz, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
February 25, 2021
COVID-19 infection in patients with mast cell disorders including mastocytosis does not impact mast cell activation symptoms
Matthew P Giannetti, Emily Weller, Iván Alvarez-Twose, et al.
Page
of 67